Home / Company / News

新闻

Latest press coverage

All Press Coverage

特朗普的"最惠国"政策将何去何从？

Rare disease drug development: challenges, support and hopes for the future

FDA to phase out animal testing with AI and lab-based models

Featured press coverage

All Press Coverage

提升医药研发效率，从数据出发

This article discusses the growing volume of raw data collected during clinical research, and how transforming the mountain of data into clinical and safety…

Featured press release

All Press Release

Certara 2025 年第一季度财务业绩报告

RADNOR, PA— 2025 年 5 月 5 日-- Certara, Inc. （纳斯达克股票代码：CERT), a global leader in model-informed drug development, today reported its financial results for the first quarter…

Latest press releases

All Press Release

Certara 将参加即将举行的投资者会议

Certara 推出 Non-Animal Navigator™ 解决方案，助力药物开发者减少对动物试验的依赖

Certara Reports Preliminary First Quarter 2025 Financial Results Announces $100 Million Share Repurchase Authorization

Recent Announcements

All Announcement

Certara Integral 数据库 25.4.1 版：REST API 功能重磅升级

Phoenix PK/PD 分析建模平台新版发布：释放系统毒理学研究新势能

Certara 连续四年荣膺 Great Place to Work Certification™

Certara 举办 Second Annual Certainty U.S. 活动

Certara 与 A2Healthcare 加速模型引导的药物开发（MIDD）在日本的落地应用

Certara 与 Biowaived 达成战略合作，强化生物制药能力

All news

提升医药研发效率，从数据出发

Certara Products - Pinnacle 21, Clinical Trials, Data Standards, Press Coverage

Certara Integral 数据库 25.4.1 版：REST API 功能重磅升级

Certara Products - Phoenix, Announcement

Phoenix PK/PD 分析建模平台新版发布：释放系统毒理学研究新势能

Certara Products, Certara Products - Phoenix, Announcement

Certara 连续四年荣膺 Great Place to Work Certification™

Certara Services, Announcement

特朗普的"最惠国"政策将何去何从？

Certara Services, Press Coverage

Certara 2025 年第一季度财务业绩报告

Certara Products, Certara Services, Press Release

Certara 将参加即将举行的投资者会议

Rare disease drug development: challenges, support and hopes for the future

Certara Services, Press Coverage

Certara 举办 Second Annual Certainty U.S. 活动

Certara Products, Certara Services, Modeling and Simulation, Announcement

Certara 推出 Non-Animal Navigator™ 解决方案，助力药物开发者减少对动物试验的依赖

建模和模拟, 新闻发布

Certara Reports Preliminary First Quarter 2025 Financial Results Announces $100 Million Share Repurchase Authorization

FDA to phase out animal testing with AI and lab-based models

Certara Products - Simcyp, Certara Services, Press Coverage

1
2
3
……
16
›

Be the first to get the latest

Transforming drug development is not just our goal—it’s our obsession. 如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。

© 2025 Certara. 保留所有权力。 | 隐私政策

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software